Opioid Attack and the Implications for Counter-Terrorism Medicine.


Journal

Prehospital and disaster medicine
ISSN: 1945-1938
Titre abrégé: Prehosp Disaster Med
Pays: United States
ID NLM: 8918173

Informations de publication

Date de publication:
Dec 2021
Historique:
pubmed: 12 10 2021
medline: 26 11 2021
entrez: 11 10 2021
Statut: ppublish

Résumé

While the opioid epidemic engulfing the United States and the globe is well-documented, the potential use of powerful fentanyl derivatives as a weapon of terror is increasingly a concern. Carfentanyl, a powerful and deadly fentanyl derivative, is seeing a surge in popularity as an illegal street drug, and there is increasing congressional interest surrounding the classification of opioid derivatives under the Chemical Weapons Convention (CWC) given their potential to cause harm. The combination of the potency of opioid derivatives along with the ease of accessibility poses a potential risk of the use of these deadly agents as chemical weapons, particularly by terrorist organizations. Disaster Medicine specialists in recent years have established a sub-specialty in Counter-Terrorism Medicine (CTM) to address and research the unique terrorism-related issues relating to mitigation, preparedness, and response measures to asymmetric, multi-modality terrorist attacks.

Identifiants

pubmed: 34629120
pii: S1049023X21001059
doi: 10.1017/S1049023X21001059
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article

Langues

eng

Pagination

661-663

Auteurs

Derrick Tin (D)

Senior Fellow, BIDMC Disaster Medicine Fellowship; Department of Emergency Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Cambridge, MassachusettsUSA.

Zachary Kallenborn (Z)

Research Affiliate, Unconventional Weapons and Technology Division, START, University of Maryland; Policy Fellow, Schar School of Policy and Government, George Mason University, Fairfax, VirginiaUSA.

Alexander Hart (A)

Director of Research, BIDMC Disaster Medicine Fellowship; Department of Emergency Medicine, Beth Israel Deaconess Medical Center; Instructor, Harvard Medical School, Cambridge, MassachusettsUSA.

Attila J Hertelendy (AJ)

Faculty, BIDMC Disaster Medicine Fellowship; Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts USA.

Gregory R Ciottone (GR)

Director, BIDMC Disaster Medicine Fellowship; Department of Emergency Medicine, Beth Israel Deaconess Medical Center; Associate Professor, Harvard Medical School, Cambridge, MassachusettsUSA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH